David S. Baskin

D233-Tmhpo Physician at Houston Methodist

Location:
6565 Fannin StreetD200, Houston, Texas, United States
Company:
Houston Methodist
HQ Phone:
(713) 790-3333
Wrong David Baskin?

Last Updated 10/26/2017

General Information

Employment History

Consulting Physician  - National Aeronautics and Space Administration (NASA)

Research Associate  - Groote Schuur Hospital

Education

Mt. Sinai School of Medicine

Swarthmore College

M.D.  - 

M.D.  - Baylor College of Medicine

M.D.  - Harvard Medical School

M.D.  - Methodist Neurological Institute

M.D.  - Ohio State University

M.D.  - The Methodist Hospital Research Institute

M.D.  - Weill-Cornell College of Medicine , New York City

MD  - National Institutes of Mental Health

Ph.D.  - Rice University's Smalley Institute for Nanoscale Science

Affiliations

Scientific Advisor  - OnKure Inc

Professor and Vice Chairman, Residency Program Director  - Texas Medical Center

Professor and Program Director  - The Methodist Hospital corporation

Research Professor  - University of Houston

Board Member  - Cure Autism Now Foundation

Scientific Advisory Boards  - National Institutes of Health

Professor  - Baylor College of Medicine

Research Associate  - University of Capetown Medical School

Founder  - The Scientific Review Council

Web References  

Spine Leaders

19. Spine surgeon leader to know: Dr. David Baskin of Houston Methodist
David Baskin, MD, is a neurosurgeon at Houston Methodist and a professor of neurosurgery at Weill Cornell Medical College.

Read More
APWU Health Plan

"Glioblastoma is the most malignant brain tumor you can have," said study co-author Dr. David Baskin, professor of neurosurgery with both Houston Methodist Hospital and the Weill-Cornell College of Medicine in New York City.
"It's almost always a death sentence, with median survival of about nine to 15 months, and the quality of life during the last five months is often quite poor. "Surgery, along with chemotherapy and radiation, is the only current treatment option," he added. "This cancer is like an octopus -- it reaches into all parts of the brain [and] you can only ever get some of it out." However, "this particular gene therapy is better than anything else we have," said Baskin, who also directs the Peak Brain Tumor Center at the Houston hospital. "By inserting a virus into the tumor, then attacking that virus with medication while also firing up the patient's own immune system, you can get a real one-two punch treatment effect, and prolonged survival." He stressed that the treatment may not be a cure. "The [survival] numbers still stink," Baskin said. "But they're significantly better, which makes this a big advance." Baskin and his team are slated to present their findings Sunday in Chicago at the annual meeting of the American Society of Clinical Oncology. The result, said Baskin, is that "suddenly the immune system starts killing anything that might have these proteins. So you put the Trojan horse virus in. Then, after you kill the virus the tumor cells explode, causing the immune system to hyper-activate without raising toxicity [to the patient]." "It's interesting and exciting, because the improvement [in survival] is significant," Baskin said. "We're not saying we have a cure, of course," noted Baskin. SOURCES: David Baskin, M.D., professor, neurosurgery, and director, Kenneth R. Peak Brain Tumor Center, Houston Methodist Hospital, Houston, Texas, and professor, neurosurgery, Weill-Cornell College of Medicine, New York City; Balveen Kaur, Ph.D., professor, neurological surgery, and associate director, Medical Center at the Comprehensive Cancer Center, Ohio State University, Columbus, Ohio; May 31, 2015, presentation, annual meeting, American Society of Clinical Oncology, Chicago, Ill.

Read More
Spine Leaders

14. Spine surgeon leader to know: Dr. David Baskin of Houston Methodist
David Baskin, MD, is a neurosurgeon at Houston Methodist and a professor of neurosurgery at Weill Cornell Medical College.

Read More

Browse ZoomInfo’s Directories